Omics-based strategies to discover novel classes of RiPP natural products. (June 2021)

• Record Type: Journal Article
• Authors: Kloosterman, Alexander M; Medema, Marnix H; van Wezel, Gilles P
• Is Part Of: Current opinion in biotechnology. Volume 69(2021)
• Page Start: 60
• Page End: 67
• Publication Date: 2021-06
• Subjects: Biotechnology -- Periodicals; 660.6
• DOI: 10.1016/j.copbio.2020.12.008
• Languages: English
• ISSNs: 0958-1669

Abstract

Highlights: As a quickly expanding and diverse class of natural products, RiPPs are an excellent target to find leads for new drugs. New gene clusters can be identified using various enzyme-coding genes as baits or by marker-independent strategies. Precursor identification by machine-learning classifiers paves the way for class-independent genome mining. Integration of transcriptomics, proteomics and metabolomics with genomic predictions can prioritize novel RiPP classes. Abstract : Ribosomally synthesized and post-translationally modified peptides (RiPPs) form a highly diverse class of natural products, with various biotechnologically and clinically relevant activities. A recent increase in discoveries of novel RiPP classes suggests that currently known RiPPs constitute just the tip of the iceberg. Genome mining has been a driving force behind these discoveries, but remains challenging due to a lack of universal genetic markers for RiPP detection. In this review, we discuss how various genome mining methodologies contribute towards the discovery of novel RiPP classes. Some methods prioritize novel biosynthetic gene clusters (BGCs) based on shared modifications between RiPP classes. Other methods identify RiPP precursors using machine-learning classifiers. The integration of such methods as well as integration with other types of omics data in more comprehensive pipelines could help these tools reach their potential, and keep pushing the boundaries of the chemical diversity of this important class of molecules.